News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News TCT 2015 First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible October 12, 2015
News Conference News TCT 2014 PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients Yael L. Maxwell September 13, 2014
News Conference News PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years November 09, 2011
News Conference News BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty November 07, 2011
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011